Submitted by Anonymous (not verified) on 25 September 2023 - 13:18
Human medicines European public assessment report (EPAR): Abiraterone Accord, abiraterone, Prostatic Neoplasms, Date of authorisation: 26/04/2021, Revision: 1, Status: Authorised
Source: